Broad Institute

We are a diverse group of creative innovators and advocates. We are committed to the development and use of biomedical interventions to address global health concerns. We are a diverse group of passionate change-makers, creative fixers and relentless advocates. We are committed to saving lives by improving the pace and predictability of translational medicine in global health. The Bill & Melinda Gates Medical Research Institute is a non-profit organization dedicated to the development and effective use of novel biomedical interventions addressing substantial global health concerns, for which investment incentives are limited. The Bill & Melinda Gates Medical Research Institute is a non-profit organization dedicated to the development and effective use of novel biomedical interventions addressing substantial global health concerns and for which the required development investment by traditional biopharmaceutical organizations is lacking.

While we are still on the ambitious path envisioned by our founders, we are taking what we’ve learned, building new capabilities and applying it to other diseases, such as Alzheimer’s disease and cancer. We are positioned with a unique interface to academia, industry and government research. At the IBRI, we are guided by five core values:. Our institute was founded on the mission to improve the health of Hoosiers who were living with diabetes. To become a leading independent research institute in the discovery and development of innovative solutions to improve human health. To build a world-class organization of researchers, innovators and business professionals that catalyze innovative research across the life sciences community. The Indiana Biosciences Research Institute (IBRI) is a leading translational research institute that advances academic and industry science through collaboration to improve patient health outcomes.

We are working to create a bridge between promising genetic research and actual medicines with the people, platform, and processes needed to advance many therapies simultaneously. We are committed to bridging this gap: between business case and scientific possibility, between patient and hope. Our goal is to not simply accept the ideas and opinions of others as fact, but instead to ask “why?” and “why not?” We endeavor to bring a rigorous, first-principles mindset to each problem that we take on. BridgeBio is committed to developing leaders as well as drugs. BridgeBio’s mission is to improve the morbidity and mortality of patients with ATTR through the discovery and development of a novel therapeutic through its affiliate, Eidos Therapeutics. To discover, create, test and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. Capabilities built to deliver genetic medicines to patients globally. Our decentralized model strives to deliver treatments from discovery to patients as fast as possible by utilizing focused teams of experts for each asset.

Our mission is to create, inspire and incubate innovative ideas in life-sciences. The main scientific focus of the institute is bioinformatics, an inter-disciplinary field of science driven by achievements in biotechnology and information technology. The fourth research area is the design of application specific integrated circuits (ASICs). The results of our work are worldwide innovative technological and biomedical solutions. Some of them are converted into commercial projects that can be disseminated across the BioInfoBank network and developed through a spin-off program.

Bridging biology and AI, to improve human health. We strive to extend the boundaries of what is possible. We help our partners and customers solve projects at all levels of complexity. We foster the spirit of innovation by promoting open-mindedness and collaboration. We build upon our shared scientific knowledge, to take responsible risks together.

We are now working with a top academic institution that has bred mice with our son's mutations in order to research the disease and develop potential treatments. Our organization is dedicated to the premise that computer technology will revolutionize healthcare, and the experience of our team reflects that conviction. We have multiple PhDs in computer science and biology, from leading institutions such as Caltech and Rockefeller University. We have MDs from Harvard and Stanford, two of the world's leading academic hospitals. So if you have specific areas of interest, we are happy to field special requests as to how your genome may relate. We report anything we can find about your DNA, so long as there is a peer-reviewed, published paper to back it up.